These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10517170)

  • 41. Fluctuation of HER2 expression in breast carcinomas during the menstrual cycle.
    Balsari A; Casalini P; Tagliabue E; Greco M; Pilotti S; Agresti R; Giovanazzi R; Alasio L; Rumio C; Cascinelli N; Colnaghi MI; Ménard S
    Am J Pathol; 1999 Nov; 155(5):1543-7. PubMed ID: 10550311
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study.
    Thorpe H; Brown SR; Sainsbury JR; Perren TJ; Hiley V; Dowsett M; Nejim A; Brown JM
    Br J Cancer; 2008 Jan; 98(1):39-44. PubMed ID: 18087287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Premenopausal node-negative breast cancer: may adjuvant chemotherapy be indicated by the analysis of nuclear DNA dynamics?
    Wyss-Desserich MT; Caduff-Joos R; Wyss P; Rageth C; Wight E; Unger C; Walt H; Haller U
    Breast Cancer Res Treat; 1997 Feb; 42(3):253-63. PubMed ID: 9065609
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.
    Tormey DC; Gray R; Falkson HC
    J Natl Cancer Inst; 1996 Dec; 88(24):1828-33. PubMed ID: 8961972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study.
    Ozaki Y; Tanabe Y; Tamura N; Ogura T; Kondoh C; Miura Y; Yoshimura K; Kawabata H; Takano T
    Breast Cancer; 2018 May; 25(3):343-349. PubMed ID: 29357022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer.
    Ejlertsen B; Mouridsen HT; Jensen MB; Bengtsson NO; Bergh J; Cold S; Edlund P; Ewertz M; de Graaf PW; Kamby C; Nielsen DL
    J Clin Oncol; 2006 Nov; 24(31):4956-62. PubMed ID: 17075113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer.
    Love RR; Hossain SM; Hussain MM; Mostafa MG; Laudico AV; Siguan SS; Adebamowo C; Sun JZ; Fei F; Shao ZM; Liu Y; Akram Hussain SM; Zhang B; Cheng L; Panigaro S; Walta F; Chuan JH; Mirasol-Lumague MR; Yip CH; Navarro NS; Huang CS; Lu YS; Ferdousy T; Salim R; Akhter C; Nahar S; Uy G; Young GS; Hade EM; Jarjoura D
    Eur J Cancer; 2016 Jun; 60():107-16. PubMed ID: 27107325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Timing of breast cancer surgery within the menstrual cycle: tumor proliferative activity, receptor status and short-term clinical outcome.
    Mangia A; De Lena M; Barletta A; Marzullo F; Attolico M; Stea B; Petroni S; Labriola A; Cellamare G; Digiesi G; Altieri R; Schittulli F; Paradiso A
    J Exp Clin Cancer Res; 1998 Sep; 17(3):317-23. PubMed ID: 9894769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer.
    Kurebayashi J; Sonoo H; Shimozuma K
    Surg Today; 1995; 25(6):519-24. PubMed ID: 7579959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
    Clahsen PC; van de Velde CJ; Julien JP; Floiras JL; Delozier T; Mignolet FY; Sahmoud TM
    J Clin Oncol; 1996 Mar; 14(3):745-53. PubMed ID: 8622020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.
    Poikonen P; Saarto T; Elomaa I; Joensuu H; Blomqvist C
    Eur J Cancer; 2000 Jan; 36(1):43-8. PubMed ID: 10741293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.
    Klijn JG; Beex LV; Mauriac L; van Zijl JA; Veyret C; Wildiers J; Jassem J; Piccart M; Burghouts J; Becquart D; Seynaeve C; Mignolet F; Duchateau L
    J Natl Cancer Inst; 2000 Jun; 92(11):903-11. PubMed ID: 10841825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
    Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J
    Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women.
    Love RR; Van Dinh N; Quy TT; Linh ND; Tung ND; Shen TZ; Hade EM; Young GS; Jarjoura D
    J Clin Oncol; 2008 Jan; 26(2):253-7. PubMed ID: 18086800
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis.
    Jatoi I
    Breast Cancer Res Treat; 1998; 52(1-3):217-25. PubMed ID: 10066084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival of premenopausal women with breast carcinoma: effects of menstrual timing of surgery.
    Harlap S; Zauber AG; Pollack DM; Tang J; Arena AE; Sternfels P; Borgen P; Norton L
    Cancer; 1998 Jul; 83(1):76-88. PubMed ID: 9655296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer.
    Badwe RA; Wang DY; Gregory WM; Fentiman IS; Chaudary MA; Smith P; Richards MA; Rubens RD
    Eur J Cancer; 1994; 30A(4):445-8. PubMed ID: 8018400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
    Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
    Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial.
    Badwe R; Hawaldar R; Parmar V; Nadkarni M; Shet T; Desai S; Gupta S; Jalali R; Vanmali V; Dikshit R; Mittra I
    J Clin Oncol; 2011 Jul; 29(21):2845-51. PubMed ID: 21670457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.